What is OCTREOTIDE ACETATE?

Octreotide acetate is a generic pharmaceutical substance. It is an injectable medicine that is quite comparable to the hormone somatostatin, which is typically provided in the figure that has particular consequences including repression of the deliverance of hormones. Octreotide operates similarly to somatostatin, but is degraded more gradually and is a more potent inhibitor of glucagon, growth hormone, including insulin freedom. Like somatostatin, octreotide likewise lessens the deliverance of growth-stimulating hormones, diminishes blood movement to the digestive organs, and represses the liberation of digestive hormones before-mentioned as serotonin, gastrin, vasoactive colonic peptide, secretin, motilin, and pancreatic polypeptide. Based on these effects, octreotide acetate is employed to treat symptoms of intractable diarrhea and flushing prompted by metastasis.

How Does OCTREOTIDE ACETATE Work?

This pharmaceutical medicine operates by lowering the number of increased hormones to standard levels. This medicine is not a remedy for certain ailments. This medication is regularly employed with additional medicines (e.g., surgery, x-rays, other drugs).

The Wholesale Price of OCTREOTIDE ACETATE

The expected per-cycle (ie, 28 days) payments of a somatostatin analog therapy were $5241.73 for 30-mg octreotide LAR and $6000 for 120-mg lanreotide, based on the ReadyPrice Wholesale Acquisition Cost, which was located on July 17, 2016.

OCTREOTIDE ACETATE Manufacturers and Suppliers

PipelinePharma has found 5 verified octreotide acetate manufacturers and octreotide acetate suppliers from our global list of sellers. The pharmaceutical drug is available for sale in different forms such as ampoules, solution for injection/infusion, injection, solution for injection, vials, lyophilized from manufacturers in various countries including South Korea, India, Brazil.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is established to simplify pharmaceutical deals by showing you an intuitive interface that is comfortable to engage with. The selection of octreotide acetate offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for octreotide acetate manufacturers and octreotide acetate suppliers that you are looking for. These also enable you to check the dossier status of octreotide acetate, and the GMP approvals of the different variants of octreotide acetate. Each manufacturer or supplier product description contains essential information about octreotide acetate, including clinical data, stability zones, and countries where octreotide acetate is already registered. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over octreotide acetate offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that octreotide acetate manufacturers have, we qualify their companies before they are on-boarded on the platform. This allows us to screen octreotide acetate manufacturers for the quality of the pharmaceutical product’s dossiers and protect against the risk of possible malpractices.